Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varsha Gandhi

Showing results (1-10 of 233) with videos related to

Pageof 24
Sort By:
Blood|September 25, 2010
Targeting kinases in CML CLLVarsha Gandhi
Gastroenterology|December 22, 2010
Yet another nucleoside analog for pancreatic cancerVarsha Gandhi
Leukemia & Lymphoma|February 28, 2007
p53 as a predictor for chemotherapy response in CLL cellsVarsha Gandhi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Questions about gemcitabine dose rate: answered or unanswered?Varsha Gandhi
Leukemia & Lymphoma|September 18, 2013
A new feature in Leukemia & Lymphoma: "Emerging drug profile"Varsha Gandhi
Seminars in Oncology|August 10, 2002
Metabolism and mechanisms of action of bendamustine: rationales for combination therapiesVarsha Gandhi
Leukemia & Lymphoma|May 9, 2012
CCL2 in chronic lymphocytic leukemia: a macro in microenvironment?Varsha Gandhi, Kumudha Balakrishnan
F1000Research|November 21, 2017
Recent therapeutic advances in chronic lymphocytic leukemiaPrithviraj Bose, Varsha Gandhi
Expert Opinion on Investigational Drugs|November 17, 2006
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphomaFarhad Ravandi, Varsha Gandhi
Expert Opinion on Investigational Drugs|March 14, 2012
Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemiaKumudha Balakrishnan, Varsha Gandhi
Pageof 24

Showing results (1-10 of 233) with videos related to

Sort By:
Pageof 24
Blood|September 25, 2010
Targeting kinases in CML CLLVarsha Gandhi
Gastroenterology|December 22, 2010
Yet another nucleoside analog for pancreatic cancerVarsha Gandhi
Leukemia & Lymphoma|February 28, 2007
p53 as a predictor for chemotherapy response in CLL cellsVarsha Gandhi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 20, 2007
Questions about gemcitabine dose rate: answered or unanswered?Varsha Gandhi
Leukemia & Lymphoma|September 18, 2013
A new feature in Leukemia & Lymphoma: "Emerging drug profile"Varsha Gandhi
Seminars in Oncology|August 10, 2002
Metabolism and mechanisms of action of bendamustine: rationales for combination therapiesVarsha Gandhi
Leukemia & Lymphoma|May 9, 2012
CCL2 in chronic lymphocytic leukemia: a macro in microenvironment?Varsha Gandhi, Kumudha Balakrishnan
F1000Research|November 21, 2017
Recent therapeutic advances in chronic lymphocytic leukemiaPrithviraj Bose, Varsha Gandhi
Expert Opinion on Investigational Drugs|November 17, 2006
Novel purine nucleoside analogues for T-cell-lineage acute lymphoblastic leukaemia and lymphomaFarhad Ravandi, Varsha Gandhi
Expert Opinion on Investigational Drugs|March 14, 2012
Protein kinases: emerging therapeutic targets in chronic lymphocytic leukemiaKumudha Balakrishnan, Varsha Gandhi
Pageof 24